ოთხშაბათი, აპრილი 15, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Botanical

Birch Leaf Extract

Betula pendula

Also known as: Silver birch extract, Betula alba leaf extract

LOW RISK 1.5/10 How?

This ingredient is classified as unclassified risk (GIRI score: 1.5/10).

02

Safety Profile

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Birch leaf extract has diuretic properties and is used for urinary tract and kidney health. It is generally safe. Its diuretic effect can interact with diuretic medications and alter electrolyte balance. People with birch pollen allergy may react to birch leaf extracts. Not recommended in those with oedema from heart or kidney failure without medical advice.

Classification

Biological and Chemical Classification

Scientific Name
Betula pendula
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Botanical
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Botanical
Ingredient Birch Leaf Extract
Scientific name Betula pendula
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Botanical
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • No significant safety signals identified in the reviewed literature.
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Birch Leaf Extract indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Birch Leaf Extract
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Betula pendula
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 26 მარ 2026, 14:36

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    Antibacterial properties of experimentally produced birch tar and its medicinal affordances in the Pleistocene. ↗
    Journal PLoS One
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Siemssen T et al.. Antibacterial properties of experimentally produced birch tar and its medicinal affordances in the Pleistocene.. PLoS One. 2026. PMID:41849267.
  2. Observational / other LOW evidence YELLOW
    Potential of Biodegradable Polyhydroxyalkanoates for the Construction of Sustainable Polymer Composite Materials. ↗
    Journal Polymers (Basel)
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Ipatova N et al.. Potential of Biodegradable Polyhydroxyalkanoates for the Construction of Sustainable Polymer Composite Materials.. Polymers (Basel). 2026. PMID:41829266.
  3. Observational / other LOW evidence YELLOW
    NaOH-Only Pretreated Wood Densification: A Simplified Sulfite-Free Route Across Wood Species. ↗
    Journal Polymers (Basel)
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Andze L et al.. NaOH-Only Pretreated Wood Densification: A Simplified Sulfite-Free Route Across Wood Species.. Polymers (Basel). 2026. PMID:41682020.
  4. Observational / other LOW evidence YELLOW
    Conduit and pit dimensions scale in a coordinated way from the treetop to coarse roots in three boreal tree species. ↗
    Journal Tree Physiol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Held M et al.. Conduit and pit dimensions scale in a coordinated way from the treetop to coarse roots in three boreal tree species.. Tree Physiol. 2026. PMID:41578849.
  5. Observational / other LOW evidence YELLOW
    Adaptive capacity of Asian populations of Lymantria dispar to non preferred plants during northward expansion. ↗
    Journal Sci Rep
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Arzhanova EL et al.. Adaptive capacity of Asian populations of Lymantria dispar to non preferred plants during northward expansion.. Sci Rep. 2026. PMID:41545486.
  6. Observational / other LOW evidence YELLOW
    Elevated environmental humidity modulates aquaporin expression and impacts leaf hydraulic efficiency in silver birch (Betula pendula). ↗
    Journal New Phytol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    u00d5unapuu-Pikas E et al.. Elevated environmental humidity modulates aquaporin expression and impacts leaf hydraulic efficiency in silver birch (Betula pendula).. New Phytol. 2026. PMID:41194426.
  7. Observational / other LOW evidence YELLOW
    Spatial and Temporal Dynamics of Birch-Mining Eriocrania Moths in an Urban Landscape over Four Decades. ↗
    Journal Insects
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Kozlov MV et al.. Spatial and Temporal Dynamics of Birch-Mining Eriocrania Moths in an Urban Landscape over Four Decades.. Insects. 2025. PMID:41598859.
  8. Observational / other LOW evidence YELLOW
    Natural pigments from the endophyte Aspergillus westerdijkiae and evaluation of their bioactivities. ↗
    Journal Microb Cell Fact
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Baskaran A et al.. Natural pigments from the endophyte Aspergillus westerdijkiae and evaluation of their bioactivities.. Microb Cell Fact. 2025. PMID:41476306.
  9. Observational / other LOW evidence YELLOW
    Anthelmintic Activity of Traditional Medicinal Plants Used in Europe. ↗
    Journal Biology (Basel)
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Boyko O et al.. Anthelmintic Activity of Traditional Medicinal Plants Used in Europe.. Biology (Basel). 2025. PMID:41463411.
  10. Observational / other LOW evidence YELLOW
    Exploring the role of BpPIN3 in hormonal regulation and branching morphogenesis of Betula pendula. ↗
    Journal BMC Plant Biol
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Chen K et al.. Exploring the role of BpPIN3 in hormonal regulation and branching morphogenesis of Betula pendula.. BMC Plant Biol. 2025. PMID:41299223.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 1.5 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 1.5 / 10

Final GIRI Score for Birch Leaf Extract. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 1.5/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
1.5

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Birch Leaf Extract

GIRI Score 1.5 / 10

A score of 1.5 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.